ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NP43325a Raltegravir

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · compiled

Tender information last checkedLast checked 29 Sept 2026, 22:28.

Opportunity overview

Supply of Raltegravir 600mg tablets to NHS Scotland.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Dr Reddy's Laboratories (UK) Ltd

Matched by exact name
Shared contract value
£1m
Awarded
Not supplied
Contract signed
8 Jul 2025
Suppliers
One of 4 awarded suppliers
Award ID
044844-2025-1
Status
active
Location
Cambridge, UK, CB4 0PE, United Kingdom

Lupin Healthcare UK Ltd

Matched by normalised name
Shared contract value
£1m
Awarded
Not supplied
Contract signed
8 Jul 2025
Suppliers
One of 4 awarded suppliers
Award ID
044844-2025-1
Status
active
Location
Slough, UKJ11, SL1 2BE, United Kingdom

Merck Sharp & Dohme UK Ltd

Match pending…
Shared contract value
£1m
Awarded
Not supplied
Contract signed
8 Jul 2025
Suppliers
One of 4 awarded suppliers
Award ID
044844-2025-1
Status
active
Location
HODDESDON, UK, EC2M 6UR., United Kingdom

Viatris UK Healthcare Ltd

Matched by exact name
Shared contract value
£1m
Awarded
Not supplied
Contract signed
8 Jul 2025
Suppliers
One of 4 awarded suppliers
Award ID
044844-2025-1
Status
active
Location
Hatfield, UKH23, AL10 9UL, United Kingdom

Classification

  • CPV33600000 — Pharmaceutical products

Lots

  • Supply of raltegravir 600mg tablets to NHS Scotland. The Authority awards this framework as a ranked multi-supplier framework to 4 Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.£2m

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-04e92b
Status
complete
Has Recurrence
No
Review Details
The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Procurement Method
open
Main Procurement Category
goods
Procurement Method Details
Open procedure

Covered By

GPA

Bid Opening

Date
3 Apr 2025, 12:00

Legal basis

Id
32014L0024
Scheme
CELEX

Techniques

Has Framework Agreement
Yes

Framework Agreement

Maximum Participants
4

Expected award period

Starts
3 Apr 2025, 12:00

Tender Period

Ends
3 Apr 2025, 12:00

Contract terms

Has Electronic Payment
Yes
Has Electronic Ordering
Yes
Electronic Invoicing Policy
allowed

Classification

Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Submission terms

Languages

en

Bid Validity Period

Duration In Days
90

Submission Method

electronicSubmission

Selection criteria

Criteria

Criterion 1
Type
suitability
Description
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015

Applies To

supplier
Criterion 2
Type
technical
Minimum
(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c) Confirmation that artwork for tendered Goods has been provided, where requested in the ITT, to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. Confirmation of artwork provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. (d) A completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder’s carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions.
Description
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the start date of the Framework Agreement. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.

Applies To

supplier

Lots and requirements

Entry 1
Id
1
Status
cancelled
Has Options
No
Has Renewal
Yes
Description
Supply of raltegravir 600mg tablets to NHS Scotland. The Authority awards this framework as a ranked multi-supplier framework to 4 Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

Value

Amount
2,030,000
Currency
GBP

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award criteria

Criteria

Criterion 1
Name
Logistics
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
300

Submission terms

Variant Policy
notAllowed

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Buyer, suppliers and contacts

Organisation 1
Id
GB-FTS-115937
Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Roles

buyer
centralPurchasingBody

Address

Region
UKM
Locality
Edinburgh
Postal Code
EH12 9EB
Country Name
United Kingdom
Street Address
1 South Gyle Crescent

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Legal Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contact

Organisation 2
Id
GB-FTS-324
Name
Sheriff Court House

Roles

reviewBody

Address

Locality
Edinburgh
Postal Code
EH1 1LB
Country Name
United Kingdom
Street Address
27 Chambers Street

Details

Identifier

Legal Name
Sheriff Court House

Contact

Telephone
+44 1312252525
Organisation 3
Id
GB-FTS-156491
Name
Lupin Healthcare UK Ltd

Roles

supplier

Address

Region
UKJ11
Locality
Slough
Postal Code
SL1 2BE
Country Name
United Kingdom
Street Address
The Urban Building, 3-8 Albert Street

Details

Scale
large

Identifier

Legal Name
Lupin Healthcare UK Ltd

Contact

Telephone
+44 7818583555
Organisation 4
Id
GB-FTS-80784
Name
Viatris UK Healthcare Ltd

Roles

supplier

Address

Region
UKH23
Locality
Hatfield
Postal Code
AL10 9UL
Country Name
United Kingdom
Street Address
Building 4, Trident Place, Mosquito Way

Details

Scale
large

Identifier

Legal Name
Viatris UK Healthcare Ltd

Contact

Telephone
+44 7586494246
Organisation 5
Id
GB-FTS-80783
Name
Dr Reddy's Laboratories (UK) Ltd

Roles

supplier

Address

Region
UK
Locality
Cambridge
Postal Code
CB4 0PE
Country Name
United Kingdom
Street Address
410, Cambridge Science Park,, Milton Road, Milton,

Details

Scale
large

Identifier

Legal Name
Dr Reddy's Laboratories (UK) Ltd

Contact

Telephone
+44 7717467751
Organisation 6
Id
GB-FTS-25701
Name
Merck Sharp & Dohme UK Ltd

Roles

supplier

Address

Region
UK
Locality
HODDESDON
Postal Code
EC2M 6UR.
Country Name
United Kingdom
Street Address
120 Moorgate, London, United Kingdom

Details

Scale
large

Identifier

Legal Name
Merck Sharp & Dohme UK Ltd

Contact

Telephone
+44 1992455245

Award information

Award 1
Id
044844-2025-1
Status
active

Suppliers

Supplier 1
Id
GB-FTS-156491
Name
Lupin Healthcare UK Ltd
Supplier 2
Id
GB-FTS-80784
Name
Viatris UK Healthcare Ltd
Supplier 3
Id
GB-FTS-80783
Name
Dr Reddy's Laboratories (UK) Ltd
Supplier 4
Id
GB-FTS-25701
Name
Merck Sharp & Dohme UK Ltd

Related lots

1

Contracts and changes

Entry 1
Id
044844-2025-1
Status
active
Award ID
044844-2025-1
Date Signed
9 Jul 2025, 00:00

Value

Amount
1,037,000
Currency
GBP

Recorded locations

  • Buyer location · Edinburgh · UKM · EH12 9EB · United Kingdom
  • Delivery location · UKM

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-04e92b-2025-07-31T15:29:08+01:00compiled ·